Siemens is already getting repeat business with the Axiom Artis dFC Magnetic Navigation System. Baptist Heart and Vascular Institute at Central Baptist Hospital was the first to buy the system, codeveloped by Siemens and Stereotaxis, and the institute is
Siemens is already getting repeat business with the Axiom Artis dFC Magnetic Navigation System. Baptist Heart and Vascular Institute at Central Baptist Hospital was the first to buy the system, codeveloped by Siemens and Stereotaxis, and the institute is the first to buy a second. The new one will be devoted to procedures in the interventional cardiology department, while the first, purchased in early 2003, remains dedicated to the hospital's electrophysiology department. The Magnetic Navigation System uses computer-controlled permanent magnets external to the body to orient the magnetic tip of specially designed catheters and guidewires.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
2 Commerce Drive
Cranbury, NJ 08512